EXOSC8 Antikörper (AA 35-276)
-
- Target Alle EXOSC8 Antikörper anzeigen
- EXOSC8 (Exosome Component 8 (EXOSC8))
-
Bindungsspezifität
- AA 35-276
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EXOSC8 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Verwendungszweck
- Anti-Human EXOSC8 Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification.
- Immunogen
- E. coli - derived recombinant Human EXOSC8 (Thr35-Lys276).
- Isotyp
- IgG
- Top Product
- Discover our top product EXOSC8 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
- Target
- EXOSC8 (Exosome Component 8 (EXOSC8))
- Andere Bezeichnung
- EXOSC8 (EXOSC8 Produkte)
- Hintergrund
- Exosome component 8, EXOSC8, OIP-2, Opa-interacting protein 2, Exosome complex component RRP43, Ribosomal RNA-processing protein 43, OIP2, RRP43, p9
- UniProt
- Q96B26
- Pathways
- SARS-CoV-2 Protein Interaktom
-